Literature DB >> 6139046

The relationship of allergies and allergy treatment to school performance and student behavior.

J McLoughlin, M Nall, B Isaacs, J Petrosko, J Karibo, B Lindsey.   

Abstract

The purposes of this project were to study the relationship of allergies and allergy treatment to school behavior. Parents of allergic and nonallergic children (grades K-12 and from different socioeconomic status) completed a survey form. The 400 parent respondents reported no significant difference between allergic and nonallergic children in terms of academic and language performance, retention, diagnosis as handicapped, or behavior problems; allergic children were absent from school more. Eustachian tube dysfunctions were significantly related to academic and behavior problems. Certain medications were related to overactive types of behavior. Parents who considered their children's behavior as inappropriate tended to contribute a portion of it to side effects of medication. 65% of the parents reported positive results from treatment on behavior at home; they tended to be unsure of the impact on school behavior. Direct relationship of allergy and allergy treatment on academic performance is questionable, except for the impact of upper respiratory problems on listening and attention. Use of certain medications with already behavior disordered children requires caution. Better communication among physicians, teachers and parents is advised.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139046

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  3 in total

1.  Allergy: Mental Effects of Long-term Theophylline Therapy in Children.

Authors:  C T Furukawa
Journal:  West J Med       Date:  1987-01

Review 2.  Neuropsychological dysfunction in asthmatic children.

Authors:  R D Annett; B G Bender
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

3.  Determination of theophylline clearance in South African children.

Authors:  J H Botha; I Tyrannes; R Miller; A Wesley
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.